Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
24 hedge funds and large institutions have $206M invested in Forward Pharma A/S American Depositary Shares in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 14 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less capital invested
Capital invested by funds: $225M → $206M (-$18.7M)
25% less funds holding
Funds holding: 32 → 24 (-8)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
+$15.7M |
| 2 |
AIM
Assured Investment Management
New York
|
+$3.97M |
| 3 |
SAM
Senzar Asset Management
New York
|
+$3.58M |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
+$846K |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$727K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$12.7M |
| 2 |
PA
Perceptive Advisors
New York
|
-$3.17M |
| 3 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$2.64M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.46M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.33M |
FWP Hedge Fund Activity: Q2 2017 in Review
24 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q2 2017, worth a combined $206M — down 8.3% from $225M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of FWP and 6 opened new positions — a net loss of 8 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was Baupost Group, adding an estimated $15.7M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $12.7M sold.
- 24 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q2 2017, down from 32 in Q1 2017.
- Funds reported $206M of Forward Pharma A/S American Depositary Shares stock for Q2 2017, down 8.3% quarter-over-quarter.
- 6 funds opened new Forward Pharma A/S American Depositary Shares positions in Q2 2017 and 14 closed out, a net change of -8 holders.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q2 2017 was Baupost Group, an estimated $15.7M added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q2 2017 was Cormorant Asset Management, an estimated $12.7M sold.
Based on aggregated 13F filings for Q2 2017.